MedTrace Logo

Paradigm Shift in the Treatment of Patients With ACS

NCT02041650 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2018-07-11

No results posted yet for this study

Summary

This protocol describes a pilot study intended to test the hypothesis that patients with acute coronary syndrome (ACS) caused by plaque erosion can be stabilized by effective antithrombotic treatment without stent implantation, thereby avoiding both early and late complications related to percutaneous coronary intervention (PCI).

Conditions

  • Acute Coronary Syndrome

Interventions

DRUG

Ticagrelor

Sponsors & Collaborators

  • Massachusetts General Hospital

    collaborator OTHER

  • Yu Bo

    lead OTHER

Principal Investigators

  • Bo Yu, MD, PhD · The Second Affiliated Hospital of Harbin Medical University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2016-04-30
Completion
2017-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02041650 on ClinicalTrials.gov